Lucia Nogova

5PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 10, 2026
Molecular and clinical characteristics of patients with non-small cell lung cancer (NSCLC) harboring KRAS Q61 mutations to assess therapeutic responses.

|Jan 14, 2025
The Value of Multidisciplinary Neuro-oncological Tumor Boards to Increase the Accuracy of FET PET for Identifying Brain Tumor Relapse.

Garry S Ceccon, Jan-Michael Werner, Maximilian I Ruge

|Apr 20, 2023
Durable Response With Sequential Tyrosine Kinase Inhibitor Treatment in a Patient With ROS1 Fusion-Positive Pancreatic Adenocarcinoma: A Case Report.

Theresa Reutter, Jana Fassunke, Michael Püsken

|Mar 08, 2022
Reproducibility of dynamic contrast enhanced MRI derived transfer coefficient Ktrans in lung cancer.

Jean-Philip Daniel Weber, Judith Eva Spiro, Matthias Scheffler

|May 22, 2020
Sorafenib and everolimus in patients with advanced solid tumors and KRAS-mutated NSCLC: A phase I trial with early pharmacodynamic FDG-PET assessment.

Lucia Nogova, Christian Mattonet, Matthias Scheffler

Pageof 1

Frequent Collaborators

3 joint publications

Matthias Scheffler

3 joint publications

Reinhard Büttner

2 joint publications

Jana Fassunke

2 joint publications

Rieke Fischer